» Articles » PMID: 15377350

Oxidative Stress is Implicated in the Pathogenesis of Lichen Sclerosus

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 2004 Sep 21
PMID 15377350
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lichen sclerosus (LS) is a chronic inflammatory skin disease of unknown aetiology which can be associated with secondary malignancies. Recent evidence supports an autoimmune basis for this disorder, as demonstrated by autoantibodies to extracellular matrix protein 1 (ECM-1). The pathophysiological mechanisms leading to autoimmunity and carcinogenesis are poorly understood.

Objectives: We hypothesized that oxidative stress, which has been demonstrated to be involved in the pathogenesis of several autoimmune and malignant disorders, contributes to these processes in LS.

Methods: Skin biopsies from 16 patients with untreated, histologically confirmed vulval LS were examined immunohistochemically using antibodies against the lipid peroxidation products malondialdehyde and 4-hydroxynonenale and against the oxidative DNA damage marker 8-hydroxy-2'-deoxyguanosine. Protein carbonyls as markers of protein oxidation were visualized using the dinitrophenylhydrazone method. Expression of antioxidant enzymes was investigated. Normal vulval tissue from 16 subjects served as control.

Results: In vulval LS tissue a significant increase of lipid peroxidation products was found particularly within the basal cell layers of the epidermis, thus colocalizing with ECM-1. Oxidative DNA damage was detected throughout LS biopsies. Intriguingly, protein oxidation was significantly increased within the dermis of LS lesions, indicating oxidative protein damage in the areas of sclerosis and inflammation. The enzymatic antioxidant defence in LS was found to be significantly disturbed.

Conclusions: This is the first study to demonstrate oxidative damage to lipids, DNA and proteins in LS, revealing a novel pathophysiological mechanism which may contribute to sclerosis, autoimmunity and carcinogenesis. Therapeutic strategies using antioxidants might be a useful new approach in the treatment of LS and could also help to prevent secondary malignancies.

Citing Articles

Vulvar Lichen Sclerosus: A Literature Review with Consideration of Integrative Therapies.

Jade K Integr Med (Encinitas). 2025; 24(1):16-25.

PMID: 39896832 PMC: 11778321.


Lack of oral involvement in a large cohort of women with vulvar lichen sclerosus - a multicenter prospective study.

Corazza M, Salvini C, Gaspari V, Simonetti O, Schettini N, de Magnis A J Dtsch Dermatol Ges. 2024; 22(12):1632-1637.

PMID: 39460471 PMC: 11626221. DOI: 10.1111/ddg.15531.


The Association between Cardiovascular Risk Factors and Lichen Sclerosus: A Systematic Review and Meta-Analysis.

Untaaveesup S, Kantagowit P, Leelakanok N, Chansate P, Eiumtrakul W, Pratchyapruit W J Clin Med. 2024; 13(16).

PMID: 39200810 PMC: 11355417. DOI: 10.3390/jcm13164668.


Sex-related Variations in Comorbidities in Lichen Sclerosus: A Systematic Review and Meta-Analysis.

Suler Baglama S, Jemec G, Zmazek J, Trcko K Acta Derm Venereol. 2024; 104():adv39982.

PMID: 39113339 PMC: 11321451. DOI: 10.2340/actadv.v104.39982.


IL-17: a novel player in the pathogenesis of vulvar lichen sclerosus.

Baran W, Wozniak Z, Batycka-Baran A Postepy Dermatol Alergol. 2024; 41(2):220-225.

PMID: 38784924 PMC: 11110226. DOI: 10.5114/ada.2024.139142.